Placebo, Saline

DRUG3 trials

Sponsors

La Jolla Pharmaceutical Company, Eurocine Vaccines AB, Bispebjerg Hospital

Conditions

Chronic Kidney DiseaseDiabetes Mellitus, Type 2Influenza, HumanKidney Disease, Chronic

Phase 1

Study to Assess the Safety, Tolerability and Immune Response Following Vaccination With Immunose™ FLU

CompletedNCT02998996

Eurocine Vaccines ABInfluenza, Human

Start: 2016-09-30End: 2017-06-01Updated: 2019-02-21

Phase 2

A Phase 2a Study of Weekly Doses of GCS-100 in Patients With Chronic Kidney Disease

CompletedNCT01843790

La Jolla Pharmaceutical CompanyChronic Kidney Disease

Start: 2013-06-30End: 2014-09-30Updated: 2015-09-01

Unknown Phase

Semaglutide's Effect on Renal Hemodynamics and Function in Patients With Type 2 Diabetes Mellitus and Nephropathy

Not yet recruitingNCT06555146

Bispebjerg HospitalDiabetes Mellitus, Type 2, Kidney Disease, Chronic

Start: 2024-08-31End: 2025-03-31Target: 15Updated: 2024-08-15